32 studies found for:
" August 10, 2011":" September 09, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
|
||||
| 2 | Recruiting |
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
|
||||
| 3 | Recruiting |
HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
|
||||
| 4 | Recruiting |
Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
|
||||
| 5 | Not yet recruiting |
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
||||
| 6 | Recruiting |
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
|
||||
| 7 | Active, not recruiting |
Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure
|
||||
| 8 |
Completed
Has Results |
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
|
||||
| 9 | Recruiting |
Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
|
||||
| 10 | Terminated |
Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
|
||||
| 11 | Active, not recruiting |
Drug Exposure Registry for GSK2248761, an Investigational NNRTI
|
||||
| 12 | Active, not recruiting |
Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
|
||||
| 13 | Enrolling by invitation |
Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144
|
||||
| 14 | Enrolling by invitation |
Safety Study of Maraviroc's Effect on Human Osteoclasts
|
||||
| 15 | Recruiting |
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
|
||||
| 16 | Recruiting |
Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi
|
||||
| 17 | Recruiting |
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
|
||||
| 18 | Completed |
Drug Interaction Study Between Dolutegravir and Prednisone
|
||||
| 19 | Completed |
A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
|
||||
| 20 | Completed |
Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/HCV Negative Volunteers
|
† Indicates status has not been verified in more than two years
